Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysis
Simona Lattanzi(Marche Polytechnic University), Filippo Dainese, Elena Tartara, Eleonora Rosati(Azienda Ospedaliero-Universitaria Careggi), Giuseppe Didato(Fondazione IRCCS Istituto Neurologico Carlo Besta), Stefano Meletti(University of Modena and Reggio Emilia), Annacarmen Nilo(University of Udine), Laura Canafoglia(Fondazione IRCCS Istituto Neurologico Carlo Besta), David Stokelj(Azienda Sanitaria Universitaria Integrata di Trieste), Alfonso Marrelli(San Salvatore Hospital), Concetta Luisi(University of Padua), Giada Pauletto(Ospedale Santa Maria della Misericordia di Udine), Paolo Bonanni(IRCCS Eugenio Medea), Valentina Chiesa(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Daniela Marino(Paul Ehrlich Institut), Giovanni De Maria(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Francesca Anzellotti(Ospedale SS. Annunziata), Federica Ranzato(International Renal Research Institute of Vicenza), Emanuele Bartolini(Meyer Children's Hospital)
Cited by 18
Related Papers
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
|Brain|2017|546
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture
|Nature Genetics|2023|219
COVID-19 pandemic: health impact of staying at home, social distancing and ‘lockdown’ measures—a systematic review of systematic reviews
|Journal of Public Health|2021|202
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
|Journal of Neurology Neurosurgery & Psychiatry|2020|199
Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3
|Nature Communications|2019|170